# Default BP Medication Intensification

> **NCT01994408** · PHASE1,PHASE2 · TERMINATED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** default intensification

## Key facts

- **NCT ID:** NCT01994408
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994408, "Default BP Medication Intensification". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01994408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*